Hannah Valantine

Professional Education

Fellowship: Stanford University School of Medicine (1986) CA

Fellowship: Hammersmith Hospital (1984) England

Residency: Brompton Hospital (1982) UK

Residency: St George's Hospital Medical School (1981) England

Internship: St Georges'S and Kingston Hosp (1979) UK

Medical Education: St George's Hospital Medical School (1978) England

MBBS, St Georges Hosp/London Univ, UK, Medicine (MD equivalent) (1978)

MRCP, London University, London, UK, Internal Medicine (1982)

Registrar, Hammersmith Hospital, London, UK, Cardiology Fellow (1984)

Fellow, Stanford University, Cardiology (1986)

MD, London University, London, UK, Cardiology (PhD equivalent) (1988)

Administrative Appointments

President, Western State Affiliation, American Heart Association, 2004

Senior Associate Dean for Diversity and Faculty Development, School of Medicine, 2005

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Hospital & Clinics patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Transdisciplinary translational science and the case of preterm birth
Stevenson, D. K., Shaw, G. M., Wise, P. H., Norton, M. E., Druzin, M. L., & McFarland, D. A. (2013). Transdisciplinary translational science and the case of preterm birth. JOURNAL OF PERINATOLOGY, 33(4), 251-258.

Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions
Epailly, E., Albanell, J., Andreassen, A., Bara, C., Campistol, J. M., & Potena, L. (2011). Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions. CLINICAL TRANSPLANTATION, 25(5), E475-E486.

Decisions, Decisions: How Program Diversity Influences Residency Program Choice
Ku, M. C., Li, Y. E., Prober, C., Valantine, H., & Girod, S. C. (2011). Decisions, Decisions: How Program Diversity Influences Residency Program Choice. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 213(2), 294-305.

Impact of Donor-Transmitted Atherosclerosis on Early Cardiac Allograft Vasculopathy: New Findings by Three-Dimensional Intravascular Ultrasound Analysis
Yamasaki, M., Sakurai, R., Hirohata, A., Honda, Y., Bonneau, H. N., & Fearon, W. F. (2011). Impact of Donor-Transmitted Atherosclerosis on Early Cardiac Allograft Vasculopathy: New Findings by Three-Dimensional Intravascular Ultrasound Analysis. TRANSPLANTATION, 91(12), 1406-1411.

Identification and Classification of Acute Cardiac Rejection by Intragraft Transcriptional Profiling
Holweg, C. Tj., Potena, L., Luikart, H., Yu, T., Berry, G. J., & Mocarski, E. S. (2011). Identification and Classification of Acute Cardiac Rejection by Intragraft Transcriptional Profiling. CIRCULATION, 123(20), 2236-U154.

Universal noninvasive detection of solid organ transplant rejection
Snyder, T. M., Khush, K. K., Valantine, H. A., & Quake, S. R. (2011). Universal noninvasive detection of solid organ transplant rejection. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 108(15), 6229-6234.

Academic Couples: Implications for Medical School Faculty Recruitment and Retention
Girod, S., Gilmartin, S. K., Valantine, H., & Schiebinger, L. (2011). Academic Couples: Implications for Medical School Faculty Recruitment and Retention. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 212(3), 310-319.

Differentially Expressed RNA from Public Microarray Data Identifies Serum Protein Biomarkers for Cross-Organ Transplant Rejection and Other Conditions
Chen, R., Sigdel, T. K., Li, L., Kambham, N., Dudley, J. T., & Butte, A. J. (2010). Differentially Expressed RNA from Public Microarray Data Identifies Serum Protein Biomarkers for Cross-Organ Transplant Rejection and Other Conditions. PLOS COMPUTATIONAL BIOLOGY, 6(9).

Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation
Pham, M. X., Teuteberg, J. J., Kfoury, A. G., Starling, R. C., Deng, M. C., & Valantine, H. A. (2010). Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation. NEW ENGLAND JOURNAL OF MEDICINE, 362(20), 1890-1900.

Changing trends in infectious disease in heart transplantation
Haddad, F., Deuse, T., Pham, M., Khazanie, P., Rosso, F., & Montoya, J. G. (2010). Changing trends in infectious disease in heart transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 29(3), 306-315.

Right Ventricular Dysfunction Predicts Poor Outcome Following Hemodynamically Compromising Rejection
Haddad, F., Fisher, P., Pham, M., Berry, G., Weisshaar, D., & Hunt, S. (2009). Right Ventricular Dysfunction Predicts Poor Outcome Following Hemodynamically Compromising Rejection. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 28(4), 312-319.

New developments in immunosuppressive therapy for heart transplantation
Khush, K. K., & Valantine, H. A. (2009). New developments in immunosuppressive therapy for heart transplantation. EXPERT OPINION ON EMERGING DRUGS, 14(1), 1-21.

Twenty-year survivors of heart transplantation at Stanford University
Deuse, T., Haddad, F., Pham, M., Hunt, S., Valantine, H., & Reitz, B. A. (2008). Twenty-year survivors of heart transplantation at Stanford University. AMERICAN JOURNAL OF TRANSPLANTATION, 8(9), 1769-1774.

Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation
Sinha, S. S., Pham, M. X., Vagelos, R. H., Perlroth, M. G., Hunt, S. A., & Fearon, W. F. (2008). Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation. AMERICAN HEART JOURNAL, 155(5).

Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: Modulation by sirolimus
Potena, L., Fearon, W. F., Sydow, K., Holweg, C., Luikart, H., & Cooke, J. P. (2008). Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: Modulation by sirolimus. TRANSPLANTATION, 85(6), 827-833.

Determinants of lumen loss between years 1 and 2 after cardiac transplantation
Sakurai, R., Yamasaki, M., Nakamura, M., Hirohata, A., Honda, Y., & Fearon, W. F. (2007). Determinants of lumen loss between years 1 and 2 after cardiac transplantation. TRANSPLANTATION, 84(9), 1097-1102.

Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness
Kuppahally, S. S., Valantine, H. A., Weisshaar, D., Parekh, H., Hung, Y. Y., & Hunt, S. A. (2007). Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness. AMERICAN JOURNAL OF TRANSPLANTATION, 7(10), 2388-2395.

Molecular testing for long-term rejection surveillance in heart transplant recipients: Design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial
Pham, M. X., Deng, M. C., Kfoury, A. G., Teuteberg, J. J., Starling, R. C., & Valantine, H. (2007). Molecular testing for long-term rejection surveillance in heart transplant recipients: Design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 26(8), 808-814.

Cytomegalovirus-associated allograft rejection in heart transplant patients
Potena, L., & Valantine, H. A. (2007). Cytomegalovirus-associated allograft rejection in heart transplant patients. CURRENT OPINION IN INFECTIOUS DISEASES, 20(4), 425-431.

Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology
Valantine, H. (2007). Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 26(6), 557-564.

Frequent occult infection with cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis
Potena, L., Holweg, C. Tj., Vana, M. L., Bashyam, L., Rajamani, J., & Mocarski, E. S. (2007). Frequent occult infection with cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis. JOURNAL OF CLINICAL MICROBIOLOGY, 45(6), 1804-1810.

Changes in coronary anatomy and physiology after heart transplantation
Hirohata, A., Nakamura, M., Waseda, K., Honda, Y., Lee, D. P., & Fearon, W. F. (2007). Changes in coronary anatomy and physiology after heart transplantation. AMERICAN JOURNAL OF CARDIOLOGY, 99(11), 1603-1607.

Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation
Biadi, O., Potena, L., Fearon, W. F., Luikart, H. I., Yeung, A., & Valantine, H. A. (2007). Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 26(4), 324-330.

Changes in coronary arterial dimensions early after cardiac transplantation
Fearon, W. F., Potena, L., Hirohata, A., Sakurai, R., Yamasaki, M., & Valantine, H. A. (2007). Changes in coronary arterial dimensions early after cardiac transplantation. TRANSPLANTATION, 83(6), 700-705.

Pulmonary nocardiosis in a heart transplant patient: Case report and review of the literature
Haddad, F., Hunt, S. A., Perlroth, M., Valantine, H., Doyle, R., & Montoya, J. (2007). Pulmonary nocardiosis in a heart transplant patient: Case report and review of the literature. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 26(1), 93-97.

Peripheral blood leukocyte counts in cytomegalovirus infected heart transplant patients: Impact of acute disease versus subclinical infection
Cooke, M. E., Potena, L., Luikart, H., & Valantine, H. A. (2006). Peripheral blood leukocyte counts in cytomegalovirus infected heart transplant patients: Impact of acute disease versus subclinical infection. TRANSPLANTATION, 82(11), 1419-1424.

Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy
Haddad, F., Perez, M., Fleischmann, D., Valantine, H., & Hunt, S. A. (2006). Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 25(11), 1367-1370.

T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease
Tu, W., Potena, L., Stepick-Biek, P., Liu, L., Dionis, K. Y., & Lewis, D. B. (2006). T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. CIRCULATION, 114(15), 1608-1615.

Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection
Potena, L., Holweg, C. Tj., Chin, C., Luikart, H., Weisshaar, D., & Valantine, H. A. (2006). Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. TRANSPLANTATION, 82(3), 398-405.

Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic investigation for transplant arteriopathy II (PITA II) study
Fearon, W. F., Hirohata, A., Nakamura, M., Luikart, H., Lee, D. P., & Yeung, A. C. (2006). Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic investigation for transplant arteriopathy II (PITA II) study. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 25(7), 765-771.

Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients
Kuppahally, S., Al-Khaldi, A., Weisshaar, D., Valantine, H. A., Oyer, P., & Hunt, S. A. (2006). Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 6(5), 986-992.

Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation
Ma, I. Wy., Valantine, H. A., Shibata, A., Waskerwitz, J., Dafoe, D. C., & Scandling, J. D. (2006). Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation. CLINICAL TRANSPLANTATION, 20(2), 139-146.

Recurrence of iron deposition in the cardiac allograft in a patient with non-HFE hemochromatosis
Kuppahally, S. S., Hunt, S. A., Valantine, H. A., & Berry, G. J. (2006). Recurrence of iron deposition in the cardiac allograft in a patient with non-HFE hemochromatosis. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 25(1), 144-147.

Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation
Ptaszek, L. M., Wang, P. J., Hunt, S. A., Valantine, H., Perlroth, M., & Al-Ahmad, A. (2005). Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation. HEART RHYTHM, 2(9), 931-933.

Induction therapy for pediatric and adult heart transplantation: Comparison between OKT3 and daclizumab
Chin, C., Pittson, S., Luikart, H., Bernstein, D., Robbins, R., & Valantine, H. (2005). Induction therapy for pediatric and adult heart transplantation: Comparison between OKT3 and daclizumab. TRANSPLANTATION, 80(4), 477-481.

From clinical trials to clinical practice: An overview of Certican((R)) (everolimus) in heart transplantation
Valantine, H., & Zuckermann, A. (2005). From clinical trials to clinical practice: An overview of Certican((R)) (everolimus) in heart transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 24(4), S185-S190.

Certican (Everolimus) in heart transplantation: from clinical trial to clinical experience. Proceedings of a meeting, Vienna, Austria, September 9, 2004.
Certican (Everolimus) in heart transplantation: from clinical trial to clinical experience. Proceedings of a meeting, Vienna, Austria, September 9, 2004. (2005). Certican (Everolimus) in heart transplantation: from clinical trial to clinical experience. Proceedings of a meeting, Vienna, Austria, September 9, 2004. journal of heart and lung transplantation , 24(4), S183-211.

Prevention of cardiac allograft vasculopathy with Certican((R)) (everolimus): The Stanford University experience within the Certican Phase III clinical trial
Valantine, H. (2005). Prevention of cardiac allograft vasculopathy with Certican((R)) (everolimus): The Stanford University experience within the Certican Phase III clinical trial. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 24(4), S191-S195.

Cardiac allograft vasculopathy after heart transplantation: Risk factors and management
Valantine, H. (2004). Cardiac allograft vasculopathy after heart transplantation: Risk factors and management. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 23(5), S187-S193.

Glucose intolerance, as reflected by hemoglobin A(1c) level, is associated with the incidence and severity of transplant coronary artery disease
Kato, T., Chan, M. Cy., Gao, S. Z., Schroeder, J. S., Yokota, M., & Valantine, H. A. (2004). Glucose intolerance, as reflected by hemoglobin A(1c) level, is associated with the incidence and severity of transplant coronary artery disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 43(6), 1034-1041.

Cytomegalovirus infection impairs the nitric oxide synthase pathway - Role of asymmetric dimethylarginine in transplant arteriosclerosis
Weis, M., Kledal, T. N., LIN, K. Y., Panchal, S. N., Gao, S. Z., & Cooke, J. P. (2004). Cytomegalovirus infection impairs the nitric oxide synthase pathway - Role of asymmetric dimethylarginine in transplant arteriosclerosis. CIRCULATION, 109(4), 500-505.

The role of viruses in cardiac allograft vasculopathy
Valantine, H. A. (2004). The role of viruses in cardiac allograft vasculopathy. AMERICAN JOURNAL OF TRANSPLANTATION, 4(2), 169-177.

Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience
Shiba, N., Chan, M. Cy., Kwok, B. Wk., Valantine, H. A., Robbins, R. C., & Hunt, S. A. (2004). Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 23(2), 155-164.

Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era
Shiba, N., Chan, M. Cy., Valantine, H. A., Gao, S. Z., Robbins, R. C., & Hunt, S. A. (2003). Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 22(10), 1098-1106.

Cardiac allograft vasculopathy: Central role of endothelial injury leading to transplant "atheroma"
Valantine, H. A. (2003). Cardiac allograft vasculopathy: Central role of endothelial injury leading to transplant "atheroma". TRANSPLANTATION, 76(6), 891-899.

Post-operative conversion from cyclosporine to tacrolimus in heart transplantation: A single-center experience
Cantin, B., Kwok, B. Wk., Shiba, N., Valantine, H. A., Hunt, S. A., & Chan, M. Cy. (2003). Post-operative conversion from cyclosporine to tacrolimus in heart transplantation: A single-center experience. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 22(7), 723-730.

Preferential involvement of larger vessels in a rat model of diabetes induced graft vasculopathy
Cantin, B., Zhu, D., Wen, P. Z., Panchal, S. N., Gwathmey, J. K., & Valantine, H. A. (2002). Preferential involvement of larger vessels in a rat model of diabetes induced graft vasculopathy. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 21(9), 1040-1043.

Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection
Chan, M. Cy., Kwok, B. W., Shiba, N., Cantin, B., Valantine, H. A., & Hunt, S. A. (2002). Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection. TRANSPLANTATION PROCEEDINGS, 34(5), 1850-1852.

Mycophenolic acid concentrations in long-term heart transplant patients: relationship with calcineurin antagonists and acute rejection
Cantin, B., Giannetti, N., Parekh, H., Panchal, S. N., Kwok, B. Wk., & Valantine, H. A. (2002). Mycophenolic acid concentrations in long-term heart transplant patients: relationship with calcineurin antagonists and acute rejection. CLINICAL TRANSPLANTATION, 16(3), 196-201.

Reversal of diabetes-induced rat graft transplant coronary artery disease by metformin
Cantin, B., Zhu, D., Wen, P., Panchal, S. N., Dai, X., & Valantine, H. A. (2002). Reversal of diabetes-induced rat graft transplant coronary artery disease by metformin. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 21(6), 637-643.

Detection of early atherosclerosis with radiolabeled monocyte chemoattractant protein-1 in prediabeteic Zucker rats
Blankenberg, F. G., Wen, P. Z., Dai, M., Zhu, D. N., Panchal, S. N., & Valantine, H. A. (2001). Detection of early atherosclerosis with radiolabeled monocyte chemoattractant protein-1 in prediabeteic Zucker rats. PEDIATRIC RADIOLOGY, 31(12), 827-835.

Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation - A comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone
Valantine, H. A., Luikart, H., Doyle, R., Theodore, J., Hunt, S., & Reitz, B. (2001). Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation - A comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone. TRANSPLANTATION, 72(10), 1647-1652.

Transplant coronary artery disease - A novel model independent of cellular alloimmune response
Cantin, B., Wen, P. Z., Zhu, D. N., Dai, M., Panchal, S. N., & Valantine, H. A. (2001). Transplant coronary artery disease - A novel model independent of cellular alloimmune response. CIRCULATION, 104(21), 2615-2619.

Detection and treatment of coronary artery disease in liver transplant candidates
Keeffe, B. G., Valantine, H., & Keeffe, E. B. (2001). Detection and treatment of coronary artery disease in liver transplant candidates. LIVER TRANSPLANTATION, 7(9), 755-761.

Mild hyperhomocysteinemia is not associated with cardiac allograft coronary disease
Giannetti, N., Herity, N. A., Alimollah, A., Gao, S. Z., Schroeder, J. S., & Valantine, H. A. (2001). Mild hyperhomocysteinemia is not associated with cardiac allograft coronary disease. CLINICAL TRANSPLANTATION, 15(4), 247-252.

Severe tricuspid regurgitation after heart transplantation
Chan, M. Cy., Giannetti, N., Kato, T., Kornbluth, M., Oyer, P., & Hunt, S. A. (2001). Severe tricuspid regurgitation after heart transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 20(7), 709-717.

Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease - A prospective study
Valantine, H., Rickenbacker, P., Kemna, M., Hunt, S., CHEN, Y. Di., & Stinson, E. B. (2001). Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease - A prospective study. CIRCULATION, 103(17), 2144-2152.

Impact of type 1 diabetes on microvascular vs. macrovascular involvement with TXCAD: is there a difference in models of the disease?
Valantine, H., Zhu, D., Wen, P., Panchal, S. N., & Dai, X. (2001). Impact of type 1 diabetes on microvascular vs. macrovascular involvement with TXCAD: is there a difference in models of the disease?. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 20(2), 186-187.

Neoral use in the cardiac transplant recipient
Valantine, H. (2000). Neoral use in the cardiac transplant recipient. TRANSPLANTATION PROCEEDINGS, 32(3A), 27S-44S.

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis - A post hoc analysis of a randomized, placebo-controlled study
Valantine, H. A., Gao, S. Z., Menon, S. G., Renlund, D. G., Hunt, S. A., & Schroeder, J. S. (1999). Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis - A post hoc analysis of a randomized, placebo-controlled study. CIRCULATION, 100(1), 61-66.

Role of CMV in transplant coronary artery disease and survival after heart transplantation.
Valantine, H. A. (1999). Role of CMV in transplant coronary artery disease and survival after heart transplantation. Transplant infectious disease , 1, 25-30.

Diabetes and dyslipidemia - A new model for transplant coronary artery disease
Hoang, K., Chen, I., Reaven, G., Zhang, L. N., Ross, H., & Valantine, H. (1998). Diabetes and dyslipidemia - A new model for transplant coronary artery disease. CIRCULATION, 97(21), 2160-2168.

Scedosporium apiospermum (Pseudallescheria boydii) infection in a heart transplant recipient: A case of mistaken identity
Lopez, F. A., Crowley, R. S., Wastila, L., Valantine, H. A., & Remington, J. S. (1998). Scedosporium apiospermum (Pseudallescheria boydii) infection in a heart transplant recipient: A case of mistaken identity. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 17(3), 321-324.

Importance of decreased heart rate in predicting transplant coronary artery disease
Gullestad, L., Ross, H., Myers, J., Hoang, K., Hunt, S., & Valentine, H. A. (1997). Importance of decreased heart rate in predicting transplant coronary artery disease. CLINICAL TRANSPLANTATION, 11(6), 628-632.

Individualizing immunosuppression for heart transplantation: Strategies for the next decade
Valantine, H. A. (1997). Individualizing immunosuppression for heart transplantation: Strategies for the next decade. TRANSPLANTATION PROCEEDINGS, 29(8A), 5S-8S.

Heart transplantation in patients over 54 years of age - Mortality, morbidity and quality of life
Rickenbacher, P. R., Lewis, N. P., Valantine, H. A., Luikart, H., Stinson, E. B., & Hunt, S. A. (1997). Heart transplantation in patients over 54 years of age - Mortality, morbidity and quality of life. EUROPEAN HEART JOURNAL, 18(5), 870-878.

Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: A comparative study
Ross, H. J., Gullestad, L., Pak, J., Slauson, S., Valantine, H. A., & Hunt, S. A. (1997). Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: A comparative study. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 16(2), 179-189.

Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis
Reichenspurner, H., Gamberg, P., Nitschke, M., Valantine, H., Hunt, S., & Reitz, B. A. (1997). Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. TRANSPLANTATION PROCEEDINGS, 29(1-2), 627-628.

Volume-mediated pulmonary responses in liver transplant candidates
Kuo, P. C., Schroeder, R. A., Vagelos, R. H., Valantine, H., Garcia, G., & Dafoe, D. C. (1996). Volume-mediated pulmonary responses in liver transplant candidates. CLINICAL TRANSPLANTATION, 10(6), 521-527.

Early Doppler echocardiographic dysfunction is associated with an increased mortality after orthotopic cardiac transplantation.
Ross, H. J., Gullestad, L., Hunt, S. A., TOVEY, D. A., PURYEAR, J. B., & Valantine, H. A. (1996). Early Doppler echocardiographic dysfunction is associated with an increased mortality after orthotopic cardiac transplantation. Circulation, 94(9), II289-93.

Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle
Lewis, N. P., Tsao, P. S., Rickenbacher, P. R., Xue, C., Johns, R. A., & Fowler, M. B. (1996). Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. CIRCULATION, 93(4), 720-729.

Coronary artery intimal thickening in the transplanted heart - An in vivo intracoronary ultrasound study of immunologic and metabolic risk factors
Rickenbacher, P. R., Kemna, M. S., Pinto, F. J., Hunt, S. A., Alderman, E. L., & Valantine, H. A. (1996). Coronary artery intimal thickening in the transplanted heart - An in vivo intracoronary ultrasound study of immunologic and metabolic risk factors. TRANSPLANTATION, 61(1), 46-53.

Prophylactic ganciclovir treatment reduces fungal as well as cytomegalovirus infections after heart transplantation
Wagner, J. A., Ross, H., Hunt, S., Gamberg, P., Valantine, H., & Stinson, E. B. (1995). Prophylactic ganciclovir treatment reduces fungal as well as cytomegalovirus infections after heart transplantation. TRANSPLANTATION, 60(12), 1473-1477.

The relationship of granzyme A and perforin expression to cardiac allograft rejection and dysfunction
Alpert, S., Lewis, N. P., Ross, H., Fowler, M., & Valantine, H. A. (1995). The relationship of granzyme A and perforin expression to cardiac allograft rejection and dysfunction. TRANSPLANTATION, 60(12), 1478-1485.

PROGNOSTIC IMPORTANCE OF INTIMAL THICKNESS AS MEASURED BY INTRACORONARY ULTRASOUND AFTER CARDIAC TRANSPLANTATION
Rickenbacher, P. R., Pinto, F. J., Lewis, N. P., Hunt, S. A., Alderman, E. L., & Valantine, H. A. (1995). PROGNOSTIC IMPORTANCE OF INTIMAL THICKNESS AS MEASURED BY INTRACORONARY ULTRASOUND AFTER CARDIAC TRANSPLANTATION. CIRCULATION, 92(12), 3445-3452.

Incidence and progression of transplant coronary artery disease over 1 year: Results of a multicenter trial with use of intravascular ultrasound
Yeung, A. C., Davis, S. F., Hauptman, P. J., Kobashigawa, J. A., Miller, L. W., & Wilensky, R. (1995). Incidence and progression of transplant coronary artery disease over 1 year: Results of a multicenter trial with use of intravascular ultrasound. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 14(6), S215-S220.

Role of lipids in allograft vascular disease: A multicenter study of intimal thickening detected by intravascular ultrasound
Valantine, H. A. (1995). Role of lipids in allograft vascular disease: A multicenter study of intimal thickening detected by intravascular ultrasound. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 14(6), S234-S237.

MAGNETIC-RESONANCE IMAGING-DERIVED PARAMETER OF PORTAL FLOW PREDICTS VOLUME-MEDIATED PULMONARY-HYPERTENSION IN LIVER-TRANSPLANTATION CANDIDATES
Kuo, P. C., Alfrey, E. J., Li, K., Vagelos, R., Valantine, H., & Dafoe, D. C. (1995). MAGNETIC-RESONANCE IMAGING-DERIVED PARAMETER OF PORTAL FLOW PREDICTS VOLUME-MEDIATED PULMONARY-HYPERTENSION IN LIVER-TRANSPLANTATION CANDIDATES. SURGERY, 118(4), 685-692.

PREVENTION AND TREATMENT OF CYTOMEGALOVIRUS DISEASE IN THORACIC ORGAN TRANSPLANT PATIENTS - EVIDENCE FOR A BENEFICIAL EFFECT OF HYPERIMMUNE GLOBULIN
Valantine, H. A. (1995). PREVENTION AND TREATMENT OF CYTOMEGALOVIRUS DISEASE IN THORACIC ORGAN TRANSPLANT PATIENTS - EVIDENCE FOR A BENEFICIAL EFFECT OF HYPERIMMUNE GLOBULIN. TRANSPLANTATION PROCEEDINGS, 27(5), 49-57.

CORRELATION OF DONOR CHARACTERISTICS WITH TRANSPLANT CORONARY-ARTERY DISEASE AS ASSESSED BY INTRACORONARY ULTRASOUND AND CORONARY ANGIOGRAPHY
RICHENBACHER, P. R., Pinto, F. J., Lewis, N. P., Hunt, S. A., Gamberg, P., & Valantine, H. A. (1995). CORRELATION OF DONOR CHARACTERISTICS WITH TRANSPLANT CORONARY-ARTERY DISEASE AS ASSESSED BY INTRACORONARY ULTRASOUND AND CORONARY ANGIOGRAPHY. AMERICAN JOURNAL OF CARDIOLOGY, 76(5), 340-345.

CLINICAL OUTCOME OF INTERVAL CADAVERIC RENAL-TRANSPLANTATION IN CARDIAC ALLOGRAFT RECIPIENTS
Kuo, P. C., Luikart, H., BUSSEHENRY, S., Hunt, S. A., Valantine, H. A., & Dafoe, D. C. (1995). CLINICAL OUTCOME OF INTERVAL CADAVERIC RENAL-TRANSPLANTATION IN CARDIAC ALLOGRAFT RECIPIENTS. CLINICAL TRANSPLANTATION, 9(2), 92-97.

CARDIAC ALLOGRAFT VASCULAR-DISEASE - RELATIONSHIP TO MICROVASCULAR CELL-SURFACE MARKERS AND INFLAMMATORY CELL PHENOTYPES ON ENDOMYOCARDIAL BIOPSY
Deng, M. C., Bell, S., Huie, P., Pinto, F., Hunt, S. A., & Valantine, H. A. (1995). CARDIAC ALLOGRAFT VASCULAR-DISEASE - RELATIONSHIP TO MICROVASCULAR CELL-SURFACE MARKERS AND INFLAMMATORY CELL PHENOTYPES ON ENDOMYOCARDIAL BIOPSY. CIRCULATION, 91(6), 1647-1654.

Distribution and morphologic features of coronary artery disease in cardiac allografts: an intracoronary ultrasound study.
Chenzbraun, A., Pinto, F. J., Alderman, E. L., Botas, J., Oesterle, S. N., & Popp, R. L. (1995). Distribution and morphologic features of coronary artery disease in cardiac allografts: an intracoronary ultrasound study. Journal of the American Society of Echocardiography , 8(1), 1-8.

INCIDENCE AND SEVERITY OF TRANSPLANT CORONARY-ARTERY DISEASE EARLY AND UP TO 15 YEARS AFTER TRANSPLANTATION AS DETECTED BY INTRAVASCULAR ULTRASOUND
Rickenbacher, P. R., Pinto, F. J., Chenzbraun, A., Botas, J., Lewis, N. P., & Yeung, A. C. (1995). INCIDENCE AND SEVERITY OF TRANSPLANT CORONARY-ARTERY DISEASE EARLY AND UP TO 15 YEARS AFTER TRANSPLANTATION AS DETECTED BY INTRAVASCULAR ULTRASOUND. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 25(1), 171-177.

FEASIBILITY OF SERIAL INTRACORONARY ULTRASOUND IMAGING FOR ASSESSMENT OF PROGRESSION OF INTIMAL PROLIFERATION IN CARDIAC TRANSPLANT RECIPIENTS
Pinto, F. J., Chenzbraun, A., Botas, J., Valantine, H. A., STGOAR, F. G., & Popp, R. L. (1994). FEASIBILITY OF SERIAL INTRACORONARY ULTRASOUND IMAGING FOR ASSESSMENT OF PROGRESSION OF INTIMAL PROLIFERATION IN CARDIAC TRANSPLANT RECIPIENTS. CIRCULATION, 90(5), 2348-2355.

IMPACT OF CYCLOSPORINE DOSE ON LONG-TERM OUTCOME AFTER HEART-TRANSPLANTATION
Valantine, H., Hunt, S., Gamberg, P., Miller, J., & Luikart, H. (1994). IMPACT OF CYCLOSPORINE DOSE ON LONG-TERM OUTCOME AFTER HEART-TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 26(5), 2710-2712.

CYTOKINES AS POTENTIAL MEDIATORS OF ACUTE ALLOGRAFT DIASTOLIC DYSFUNCTION IN CYCLOSPORINE-TREATED PATIENTS - A PILOT-STUDY USING IN-SITU HYBRIDIZATION
Valantine, H., Johnson, F., Dong, C., Lewis, N., Tovey, D., & Sibley, R. (1994). CYTOKINES AS POTENTIAL MEDIATORS OF ACUTE ALLOGRAFT DIASTOLIC DYSFUNCTION IN CYCLOSPORINE-TREATED PATIENTS - A PILOT-STUDY USING IN-SITU HYBRIDIZATION. TRANSPLANTATION PROCEEDINGS, 26(5), 2852-2853.

Cytokine gene expression in human cardiac allograft recipients.
Wu, C. J., Kurbegov, D., Lattin, B., Burchard, E., Finkle, C., & CLAYBERGER, C. (1994). Cytokine gene expression in human cardiac allograft recipients. Transplant immunology, 2(3), 199-207.

CARDIAC TRANSPLANTATION - THE STANFORD EXPERIENCE IN THE CYCLOSPORINE ERA
Sarris, G. E., Moore, K. A., Schroeder, J. S., Hunt, S. A., Fowler, M. B., & Shumway, N. E. (1994). CARDIAC TRANSPLANTATION - THE STANFORD EXPERIENCE IN THE CYCLOSPORINE ERA. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 108(2), 240-252.

EXERCISE ECHOCARDIOGRAPHY IN HEAT TRANSPLANT RECIPIENTS - A COMPARISON WITH ANGIOGRAPHY AND INTRACORONARY ULTRASONOGRAPHY
COLLINGS, C. A., Pinto, F. J., Valantine, H. A., Popylisen, S., Puryear, J. V., & Schnittger, I. (1994). EXERCISE ECHOCARDIOGRAPHY IN HEAT TRANSPLANT RECIPIENTS - A COMPARISON WITH ANGIOGRAPHY AND INTRACORONARY ULTRASONOGRAPHY. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 13(4), 604-613.

METABOLIC RISK-FACTORS FOR ATHEROSCLEROSIS IN HEART-TRANSPLANT RECIPIENTS
Kemna, M. S., Valantine, H. A., Hunt, S. A., Schroeder, J. S., CHEN, Y. Di., & Reaven, G. M. (1994). METABOLIC RISK-FACTORS FOR ATHEROSCLEROSIS IN HEART-TRANSPLANT RECIPIENTS. AMERICAN HEART JOURNAL, 128(1), 68-72.

RECOVERY OF THE RIGHT VENTRICLE AFTER SINGLE-LUNG TRANSPLANTATION IN PULMONARY-HYPERTENSION
Kramer, M. R., Valantine, H. A., Marshall, S. E., Starnes, V. A., & Theodore, J. (1994). RECOVERY OF THE RIGHT VENTRICLE AFTER SINGLE-LUNG TRANSPLANTATION IN PULMONARY-HYPERTENSION. AMERICAN JOURNAL OF CARDIOLOGY, 73(7), 494-500.

INFLUENCE OF GRAFT-REJECTION ON INCIDENCE OF ACCELERATED GRAFT CORONARY-ARTERY DISEASE - A NEW APPROACH TO ANALYSIS
Gao, S. Z., Schroeder, J. S., Hunt, S. A., Valantine, H. A., Hill, I. R., & Stinson, E. B. (1993). INFLUENCE OF GRAFT-REJECTION ON INCIDENCE OF ACCELERATED GRAFT CORONARY-ARTERY DISEASE - A NEW APPROACH TO ANALYSIS. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 12(6), 1029-1035.

INTRACORONARY ULTRASOUND IMAGING IN HEART-TRANSPLANT RECIPIENTS - THE STANFORD EXPERIENCE
Valantine, H., Pinto, F. J., STGOAR, F. G., Alderman, E. L., & Popp, R. L. (1992). INTRACORONARY ULTRASOUND IMAGING IN HEART-TRANSPLANT RECIPIENTS - THE STANFORD EXPERIENCE. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 11(3), S60-S64.

INTRACORONARY ULTRASOUND IN CARDIAC TRANSPLANT RECIPIENTS - INVIVO EVIDENCE OF ANGIOGRAPHICALLY SILENT INTIMAL THICKENING
STGOAR, F. G., Pinto, F. J., Alderman, E. L., Valantine, H. A., Schroeder, J. S., & Popp, R. L. (1992). INTRACORONARY ULTRASOUND IN CARDIAC TRANSPLANT RECIPIENTS - INVIVO EVIDENCE OF ANGIOGRAPHICALLY SILENT INTIMAL THICKENING. CIRCULATION, 85(3), 979-987.

COST CONTAINMENT - COADMINISTRATION OF DILTIAZEM WITH CYCLOSPORINE AFTER HEART-TRANSPLANTATION
Valantine, H., Keogh, A., McIntosh, N., Hunt, S., Oyer, P., & Schroeder, J. (1992). COST CONTAINMENT - COADMINISTRATION OF DILTIAZEM WITH CYCLOSPORINE AFTER HEART-TRANSPLANTATION. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 11(1), 1-8.

NITROGLYCERIN-INDUCED CORONARY VASODILATION IN CARDIAC TRANSPLANT RECIPIENTS - EVALUATION WITH INVIVO INTRACORONARY ULTRASOUND
Pinto, F. J., STGOAR, F. G., Fischell, T. A., Stadius, M. L., Valantine, H. A., & Popp, R. L. (1992). NITROGLYCERIN-INDUCED CORONARY VASODILATION IN CARDIAC TRANSPLANT RECIPIENTS - EVALUATION WITH INVIVO INTRACORONARY ULTRASOUND. CIRCULATION, 85(1), 69-77.

SENSITIVITY AND SPECIFICITY OF DIASTOLIC INDEXES FOR REJECTION SURVEILLANCE - TEMPORAL CORRELATION WITH ENDOMYOCARDIAL BIOPSY
Valantine, H. A., YEOH, T. K., Gibbons, R., McCarthy, P., Stinson, E. B., & Popp, R. L. (1991). SENSITIVITY AND SPECIFICITY OF DIASTOLIC INDEXES FOR REJECTION SURVEILLANCE - TEMPORAL CORRELATION WITH ENDOMYOCARDIAL BIOPSY. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 10(5), 757-765.

FREQUENCY AND MECHANISM OF BRADYCARDIA IN CARDIAC TRANSPLANT RECIPIENTS AND NEED FOR PACEMAKERS
Dibiase, A., Tse, T. M., Schnittger, I., Wexler, L., Stinson, E. B., & Valantine, H. A. (1991). FREQUENCY AND MECHANISM OF BRADYCARDIA IN CARDIAC TRANSPLANT RECIPIENTS AND NEED FOR PACEMAKERS. AMERICAN JOURNAL OF CARDIOLOGY, 67(16), 1385-1389.

CHANGES IN CARDIAC MORPHOLOGY AND FUNCTION FOLLOWING SINGLE-LUNG TRANSPLANTATION
YEOH, T. K., Kramer, M. R., Marshall, S., Theodore, J., Gibbons, R., & Starnes, V. A. (1991). CHANGES IN CARDIAC MORPHOLOGY AND FUNCTION FOLLOWING SINGLE-LUNG TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 23(1), 1226-1227.

LEFT-VENTRICULAR DIASTOLIC FUNCTION - DOPPLER ECHOCARDIOGRAPHIC CHANGES SOON AFTER CARDIAC TRANSPLANTATION
STGOAR, F. G., Gibbons, R., Schnittger, I., Valantine, H. A., & Popp, R. L. (1990). LEFT-VENTRICULAR DIASTOLIC FUNCTION - DOPPLER ECHOCARDIOGRAPHIC CHANGES SOON AFTER CARDIAC TRANSPLANTATION. CIRCULATION, 82(3), 872-878.

Variability of Doppler echocardiographic indexes of left ventricular filling in transplant recipients and in normal subjects.
Valantine, H. A., Hatle, L. K., Appleton, C. P., Gibbons, R., & Popp, R. L. (1990). Variability of Doppler echocardiographic indexes of left ventricular filling in transplant recipients and in normal subjects. Journal of the American Society of Echocardiography , 3(4), 276-284.

SERIAL MEASUREMENT OF INTEGRATED ULTRASONIC BACKSCATTER IN HUMAN CARDIAC ALLOGRAFTS FOR THE RECOGNITION OF ACUTE REJECTION
Masuyama, T., Valantine, H. A., Gibbons, R., Schnittger, I., & Popp, R. L. (1990). SERIAL MEASUREMENT OF INTEGRATED ULTRASONIC BACKSCATTER IN HUMAN CARDIAC ALLOGRAFTS FOR THE RECOGNITION OF ACUTE REJECTION. CIRCULATION, 81(3), 829-839.

CARDIAC TRANSPLANTATION IN PATIENTS WITH PREEXISTING NEOPLASTIC DISEASES
Edwards, B. S., Hunt, S. A., Fowler, M. B., Valantine, H. A., Stinson, E. B., & Schroeder, J. S. (1990). CARDIAC TRANSPLANTATION IN PATIENTS WITH PREEXISTING NEOPLASTIC DISEASES. AMERICAN JOURNAL OF CARDIOLOGY, 65(7), 501-504.

Long-term management and results in heart transplant recipients.
Valantine, H. A. (1990). Long-term management and results in heart transplant recipients. Cardiology clinics, 8(1), 141-148.

Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.
Gao, S. Z., Schroeder, J. S., Alderman, E. L., Hunt, S. A., Valantine, H. A., & Stinson, E. B. (1989). Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens. Circulation, 80(5), III100-5.

RECURRENCE OF AMYLOID IN A CARDIAC ALLOGRAFT 4 MONTHS AFTER TRANSPLANTATION
Valantine, H. A., & Billingham, M. E. (1989). RECURRENCE OF AMYLOID IN A CARDIAC ALLOGRAFT 4 MONTHS AFTER TRANSPLANTATION. JOURNAL OF HEART TRANSPLANTATION, 8(4), 337-341.

FREQUENCY OF FAMILIAL NATURE OF DILATED CARDIOMYOPATHY AND USEFULNESS OF CARDIAC TRANSPLANTATION IN THIS SUBSET
Valantine, H. A., Hunt, S. A., Fowler, M. B., Billingham, M. E., & Schroeder, J. S. (1989). FREQUENCY OF FAMILIAL NATURE OF DILATED CARDIOMYOPATHY AND USEFULNESS OF CARDIAC TRANSPLANTATION IN THIS SUBSET. AMERICAN JOURNAL OF CARDIOLOGY, 63(13), 959-963.

INCREASING PERICARDIAL-EFFUSION IN CARDIAC TRANSPLANT RECIPIENTS
Valantine, H. A., Hunt, S. A., Gibbons, R., Billingham, M. E., Stinson, E. B., & Popp, R. L. (1989). INCREASING PERICARDIAL-EFFUSION IN CARDIAC TRANSPLANT RECIPIENTS. CIRCULATION, 79(3), 603-609.

INCREASED BETA-RECEPTOR DENSITY AND IMPROVED HEMODYNAMIC-RESPONSE TO CATECHOLAMINE STIMULATION DURING LONG-TERM METOPROLOL THERAPY IN HEART-FAILURE FROM DILATED CARDIOMYOPATHY
HEILBRUNN, S. M., Shah, P., Bristow, M. R., Valantine, H. A., Ginsburg, R., & Fowler, M. B. (1989). INCREASED BETA-RECEPTOR DENSITY AND IMPROVED HEMODYNAMIC-RESPONSE TO CATECHOLAMINE STIMULATION DURING LONG-TERM METOPROLOL THERAPY IN HEART-FAILURE FROM DILATED CARDIOMYOPATHY. CIRCULATION, 79(3), 483-490.

A HEMODYNAMIC AND DOPPLER ECHOCARDIOGRAPHIC STUDY OF VENTRICULAR-FUNCTION IN LONG-TERM CARDIAC ALLOGRAFT RECIPIENTS - ETIOLOGY AND PROGNOSIS OF RESTRICTIVE-CONSTRICTIVE PHYSIOLOGY
Valantine, H. A., Appleton, C. P., Hatle, L. K., Hunt, S. A., Billingham, M. E., & Popp, R. L. (1989). A HEMODYNAMIC AND DOPPLER ECHOCARDIOGRAPHIC STUDY OF VENTRICULAR-FUNCTION IN LONG-TERM CARDIAC ALLOGRAFT RECIPIENTS - ETIOLOGY AND PROGNOSIS OF RESTRICTIVE-CONSTRICTIVE PHYSIOLOGY. CIRCULATION, 79(1), 66-75.

CARDIAC TRANSPLANTATION
Valantine, H. A., & Schroeder, J. S. (1989). CARDIAC TRANSPLANTATION. INTENSIVE CARE MEDICINE, 15(5), 283-289.

Changes in Doppler echocardiographic indexes of left ventricular function as potential markers of acute cardiac rejection.
Valantine, H. A., Fowler, M. B., Hunt, S. A., NAASZ, C., Hatle, L. K., & Popp, R. L. (1987). Changes in Doppler echocardiographic indexes of left ventricular function as potential markers of acute cardiac rejection. Circulation, 76(5), V86-92.

Cardiac sarcoidosis: response to steroids and transplantation.
Valantine, H. A., Tazelaar, H. D., Macoviak, J., MULLIN, A. V., Hunt, S. A., & Schroeder, J. S. (1987). Cardiac sarcoidosis: response to steroids and transplantation. journal of heart transplantation, 6(4), 244-250.